Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.

Rodríguez E, Mateo I, Infante J, Llorca J, Berciano J, Combarros O.

J Neurol. 2006 Feb;253(2):181-5. Epub 2005 Aug 17.

PMID:
16096813
2.

Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.

Agarwal R, Tripathi CB.

Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):575-82. Review.

PMID:
25551132
3.

CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease.

Li L, Yin Z, Liu J, Li G, Wang Y, Yan J, Zhou H.

J Neurol. 2013 Jul;260(7):1701-8. doi: 10.1007/s00415-012-6690-4. Epub 2012 Oct 16. Review.

PMID:
23070465
5.

The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts.

Heffernan AL, Chidgey C, Peng P, Masters CL, Roberts BR.

J Mol Neurosci. 2016 Nov;60(3):316-324. Epub 2016 Aug 6. Review.

6.

Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review.

Rasmussen KL.

Atherosclerosis. 2016 Dec;255:145-155. doi: 10.1016/j.atherosclerosis.2016.10.037. Epub 2016 Oct 20. Review.

PMID:
28340945
7.

CETP and exchangeable apoproteins: common features in lipid binding activity.

Bolaños-García VM, Soriano-García M, Mas-Oliva J.

Mol Cell Biochem. 1997 Oct;175(1-2):1-10. Review.

PMID:
9350027
8.

Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Xiao T, Jiao B, Zhang W, Tang B, Shen L.

CNS Drugs. 2016 Oct;30(10):899-907. doi: 10.1007/s40263-016-0356-1. Review.

PMID:
27282366

Supplemental Content

Support Center